资讯

Ophthalmology Times20 小时
Perfuse Therapeutics shares positive results from Phase 2 clinical trials of PER-001
Perfuse Therapeutics reveals promising Phase 2 trial results for PER-001, a potential treatment for glaucoma and diabetic ...